21 – 30 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Transient inhibition of NF-κB signaling enhances ex vivo propagation of human hematopoietic stem cells
(
- Contribution to journal › Article
-
Mark
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
(
- Contribution to journal › Article
-
Mark
Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
(
- Contribution to journal › Article
-
Mark
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma : Results from the collaboration to collect autologous transplant outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT chronic malignancies working party
(
- Contribution to journal › Article
-
Mark
A novel variant glanzmann thrombasthenia due to co-inheritance of a loss-and a gain-of-function mutation of ITGB3 : Evidence of a dominant effect of gain-of-function mutations
(
- Contribution to journal › Letter
-
Mark
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels
(
- Contribution to journal › Letter
-
Mark
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy
(
- Contribution to journal › Letter
- 2017
-
Mark
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
(
- Contribution to journal › Letter